Trial Profile
Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy Combined With Erythropoietin in Children With Cerebral Palsy: a Double-blind, Randomized, Placebo-controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary) ; Cord blood stem cell therapy
- Indications Cerebral palsy
- Focus Registrational; Therapeutic Use
- Acronyms UCBnEPOinCP
- 10 Oct 2017 Status changed from recruiting to completed.
- 12 Jan 2014 New source identified and integrated (Clinical Research Information Service (CriS)- Republic of Korea; KCT0000950)
- 29 Nov 2013 New trial record